Designing Pediatric Investigation Plans for Rare Disease Treatments
Designing Pediatric Investigation Plans for Rare Disease Treatments How to Effectively Develop Pediatric Investigation Plans for Rare Disease Drugs What Is a Pediatric Investigation Plan (PIP) and Why It Matters A Pediatric Investigation Plan (PIP) is a regulatory requirement in the European Union (EU) for all new medicines, including those intended for rare diseases. Administered…
Read More “Designing Pediatric Investigation Plans for Rare Disease Treatments” »